BEAM
Price
$25.26
Change
+$0.31 (+1.24%)
Updated
Sep 21 closing price
Capitalization
2.58B
48 days until earnings call
Intraday BUY SELL Signals
BHVN
Price
$14.22
Change
+$0.60 (+4.41%)
Updated
Sep 21, 04:59 PM (EDT)
Capitalization
2.06B
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs BHVN

BEAM vs BHVN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. BHVN commentary
Sep 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and BHVN is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.58B) has a higher market cap than BHVN($2.06B). BHVN YTD gains are higher at: 20.638 vs. BEAM (-8.874). BEAM has higher annual earnings (EBITDA): -355.78M vs. BHVN (-557.12M). BEAM has more cash in the bank: 1.15B vs. BHVN (268M). BEAM has less debt than BHVN: BEAM (247M) vs BHVN (297M). BEAM has higher revenues than BHVN: BEAM (156M) vs BHVN (0).
BEAMBHVNBEAM / BHVN
Capitalization2.58B2.06B125%
EBITDA-355.78M-557.12M64%
Gain YTD-8.87420.638-43%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash1.15B268M430%
Total Debt247M297M83%
FUNDAMENTALS RATINGS
BEAM vs BHVN: Fundamental Ratings
BEAM
BHVN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
6346
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (25) in the null industry is somewhat better than the same rating for BHVN (90) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew somewhat faster than BHVN’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew similarly to BHVN’s over the last 12 months.

BEAM's SMR Rating (92) in the null industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew similarly to BHVN’s over the last 12 months.

BHVN's Price Growth Rating (46) in the Pharmaceuticals Major industry is in the same range as BEAM (63) in the null industry. This means that BHVN’s stock grew similarly to BEAM’s over the last 12 months.

BHVN's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as BEAM (100) in the null industry. This means that BHVN’s stock grew similarly to BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMBHVN
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
74%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 27 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
N/A
COMPARISON
Comparison
Sep 22, 2026
Stock price -- (BEAM: $25.26 vs. BHVN: $13.62)
Brand notoriety: BEAM and BHVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 100% vs. BHVN: 230%
Market capitalization -- BEAM: $2.58B vs. BHVN: $2.06B
BEAM [@Biotechnology] is valued at $2.58B. BHVN’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $128.84B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green while BHVN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • BHVN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while BHVN’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 6 bearish.
  • BHVN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BEAM and BHVN are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +4.73% price change this week, while BHVN (@Biotechnology) price change was +7.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.13%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was +5.00%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

BHVN is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BEAM
Daily Signal:
Gain/Loss:
BHVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PLTA20.691.25
+6.41%
ProShares Ultra PLTR (PLTA)
TDI47.760.98
+2.10%
Touchstone Dynamic International ETF (TDI)
AVEE69.631.16
+1.70%
Avantis Emerging Markets Small Cap Equity ETF (AVEE)
URSP48.590.38
+0.80%
ProShares Ultra S&P 500 Equal Weight (URSP)
RVT17.460.13
+0.75%
Royce Value Trust

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with BCYC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-1.94%
BCYC - BHVN
44%
Loosely correlated
-0.82%
VCYT - BHVN
43%
Loosely correlated
-1.91%
NGNE - BHVN
40%
Loosely correlated
-0.99%
SLDB - BHVN
39%
Loosely correlated
+0.45%
BEAM - BHVN
38%
Loosely correlated
+1.13%
More